HealthEquity Q1 Adj $0.80 Beats $0.66 Estimate, Sales $287.60M Beat $278.11M Estimate
Portfolio Pulse from Benzinga Newsdesk
HealthEquity (NASDAQ:HQY) reported strong Q1 results, with adjusted earnings per share of $0.80 beating the estimate of $0.66 and sales of $287.60 million surpassing the $278.11 million estimate. This represents significant year-over-year growth in both earnings and sales.
June 03, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity reported strong Q1 results, with adjusted EPS of $0.80 beating the estimate of $0.66 and sales of $287.60 million surpassing the $278.11 million estimate. This represents significant year-over-year growth in both earnings and sales.
HealthEquity's strong Q1 performance, with both earnings and sales significantly beating estimates and showing substantial year-over-year growth, is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100